Search
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
biogen
biogen
Page 3 of 4
Newsletters
Pharma vet and former Biogen chief to lead biotech industry’s coronavirus response
By
Sy Mukherjee
March 2, 2020
Newsletters
Biogen is doubling down on Alzheimer’s with a massive gene therapy deal
By
Sy Mukherjee
February 28, 2020
Leadership
Biogen CEO on Controversial Alzheimer’s Drug: ‘There Is Hope’
By
Susie Gharib
December 6, 2019
Newsletters
The Broader Implications of Biogen’s Divisive Alzheimer’s Drug
By
Sy Mukherjee
December 5, 2019
Newsletters
Biogen Stock Falls After Analyst Throws Cold Water on Its Alzheimer’s Drug Bet
By
Sy Mukherjee
December 2, 2019
Newsletters
Let’s Talk About Biogen’s Stunning Alzheimer’s Drug Reversal: Brainstorm Health
By
Sy Mukherjee
October 23, 2019
Biogen Acquires Nightstar Therapeutics in $800 Million Gene Therapy Deal
By
Don Reisinger
March 4, 2019
Health
Why the Latest Alzheimer’s Drug Study Has So Many People Confused
By
Clifton Leaf
July 30, 2018
Health
Biogen’s Stock Is Soaring Because of Its Experimental Alzheimer’s Drug — But Some Are Urging Caution
By
Sy Mukherjee
July 6, 2018
Health
Alzheimer’s Cases Are Expected to Double By 2060 and We’re Not Ready for It
By
Sy Mukherjee
December 7, 2017
Health
We’ve Had Terrible Luck Trying to Cure Alzheimer’s. But What If We Could Prevent It?
By
Sy Mukherjee
November 2, 2017
Health
Could a New Immunotherapy Medical Approach Break the Alzheimer’s Drug Curse?
By
Sy Mukherjee
October 24, 2017
Health
Goldman Sachs Bet on Biogen’s Potential Landmark Alzheimer’s Drug Props Up Stock
By
Sy Mukherjee
August 16, 2017
Tech
Do You Really Want to Love Your Medicines?
By
Adam Lashinsky
June 19, 2017
Health
Here’s Why Biogen Is Forking Over $1.25 Billion to a Small Danish Biotech
By
Sy Mukherjee
January 17, 2017
Most Popular
Economy
The $38 trillion national debt is to blame for over $1 trillion in annual interest payments from here on out, CRFB says
By
Nick Lichtenberg
AI
Meta’s 28-year-old billionaire prodigy says the next Bill Gates will be a 13-year-old who is ‘vibe coding’ right now
By
Eva Roytburg
Success
As graduates face a ‘jobpocalypse,’ Goldman Sachs exec tells Gen Z they need to know their commercial impact
By
Preston Fore